The development of artificial intelligence (AI) has increased dramatically in the last 20 years,
with clinical applications progressively being explored for most of the medical specialties …

Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis
and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly …

Background Recent evidence suggests a role for the microbiome in pancreatic ductal
adenocarcinoma (PDAC) aetiology and progression. Objective To explore the faecal and …

Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with
around 9% of patients surviving> 5 years. Asymptomatic in its initial stages, PDAC is mostly …

Abstract The role of Artificial Intelligence and Machine Learning in cancer research offers
several advantages, primarily scaling up the information processing and increasing the …

Due to diagnostic improvements, medical diagnostics is demanding non-invasive or
minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can …

Despite substantial research, pancreatic cancer has a terrible prognosis by having a survival
rate of five years only. The premise behind early detection and better survival is that more …

The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly attributed to late
diagnosis. We assessed the predictive performance of our previously reported urine …

Background The overall poor prognosis in pancreatic cancer is related to late clinical
detection. Early diagnosis remains a considerable challenge in pancreatic cancer …

Pancreatic cancer, an exceptionally malignant tumor of the digestive system, presents a
challenge due to its lack of typical early symptoms and highly invasive nature. The majority …